GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: ATI-501 | ATI50001 | ATI501 | example 103 [WO2007070872A1]
Compound class:
Synthetic organic
Comment: ATI-50001 (ATI-501) is an orally bioactive kinase inhibitor, with selectivity for Janus kinases (JAK) 1/3. It was claimed in Rigel Pharmaceuticals' 2007 patent WO2007070872A1 [1], but it was later developed by Aclaris Therapeutics.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| 3-[[2-(3,4,5-trimethoxyanilino)-7H-purin-6-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide |
Synonyms ![]() |
| ATI-501 | ATI50001 | ATI501 | example 103 [WO2007070872A1] |
Database Links ![]() |
|
| CAS Registry No. | 942137-77-1 (source: PubChem) |
| GtoPdb PubChem SID | 479821108 |
| PubChem CID | 23585272 |
| Search Google for chemical match using the InChIKey | NDUGGMXIZKDJRM-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | NDUGGMXIZKDJRM |
| UniChem Compound Search for chemical match using the InChIKey | NDUGGMXIZKDJRM-UHFFFAOYSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | NDUGGMXIZKDJRM-UHFFFAOYSA-N |